1.circ_0092315 Promotes Proliferation and Invasion of Papillary Thyroid Carcinoma Cells via Regulating microRNA-1256/High Mobility Group A2 axis.
Shu-Hong KE ; Cai-Xia KONG ; Yao XU ; Cong PENG
Acta Academiae Medicinae Sinicae 2023;45(1):16-21
Objective To investigate the role and mechanism of circ_0092315 in the proliferation and invasion of papillary thyroid carcinoma cells. Methods The expression of circ_0092315 in papillary thyroid carcinoma cells was examined by real-time fluorescence quantitative PCR.The proliferation and invasion of TPC-1 cells was assessed by CCK-8 and Transwell assays.The protein level of high mobility group A2 (HMGA2) was determined by Western blotting.The regulatory relationship of circ_0092315,microRNA-1256 (miR-1256),and HMGA2 was explored by bioinformatics tools,dual-luciferase reporter assay,real-time fluorescence quantitative PCR,and Western blotting. ++++Results circ_0092315 was overexpressed in papillary thyroid carcinoma cells (all P<0.001).circ_0092315 promoted the proliferation and invasion of TPC-1 cells (all P<0.001).The transfection of si-circ_0092315 up-regulated the expression of miR-1256 (P<0.001),and miR-1256 inhibitor up-regulated the protein level of HMGA2 (P<0.001). ++++Conclusion circ_0092315 is overexpressed in TPC-1 cells and it promotes the proliferation and invasion of TPC-1 cells by regulating the miR-1256/HMGA2 axis.
Humans
;
Thyroid Cancer, Papillary/genetics*
;
Computational Biology
;
Thyroid Neoplasms/genetics*
;
Cell Proliferation
;
MicroRNAs/genetics*
2.Research advances in molecular pathogenesis of thyroid cancer.
Maotihan ALEHA ; Qing-bin MENG ; Jian-chun YU ; Wei-ming KANG ; Zhan-jiang CAO ; Shu-bo TIAN
Acta Academiae Medicinae Sinicae 2013;35(4):382-385
Thyroid cancer is the one of the most common endocrine tumors. The biological behaviors and prognoses of the thyroid cancer of different histological types remarkably differ. The highly invasive thyroid cancer responds poorly to traditional therapies. Recent research advances in the molecular mechanisms of the pathogenesis of thyroid cancer have revealed the roles of many genetic and epigenetic variations such as gene mutation, abnormal gene amplification, and abnormal gene methylation in the development of thyroid cancer, which provides new insights in the molecular diagnosis, prognosis, and target therapy of the thyroid cancer.
Carcinoma
;
genetics
;
Humans
;
Mutation
;
Signal Transduction
;
Thyroid Neoplasms
;
genetics
5.A three-microRNA panel in serum as novel biomarker for papillary thyroid carcinoma diagnosis.
Xuan ZOU ; Feng GAO ; Zhi-Yan WANG ; Huo ZHANG ; Qing-Xie LIU ; Lin JIANG ; Xin ZHOU ; Wei ZHU
Chinese Medical Journal 2020;133(21):2543-2551
BACKGROUND:
Accumulating evidence has revealed that circulating microRNAs (miRNAs) can serve as non-invasive biomarkers for cancer diagnosis. This study aimed to identify differentially expressed miRNAs in serum which might become potential biomarkers for non-invasive diagnosis of papillary thyroid carcinoma (PTC).
METHODS:
The experiment was carried out between 2015 and 2017. In the screening stage, the Exiqon miRNA quantitative real-time polymerase chain reaction (qPCR) panel was applied to select candidate miRNAs. In the following training, testing, and external validation stages, the serum samples of 100 patients and 96 healthy controls (HCs) were analyzed to compare the expression levels of the identified miRNAs. The areas under the receiver operating characteristic curves (AUCs) were calculated to assess the diagnostic value of the identified signature.
RESULTS:
Three miRNAs (miR-25-3p, miR-296-5p, and miR-92a-3p) in serum were consistently up-regulated in PTC patients compared with HCs. A three-miRNA panel was constructed by logistic regression analysis and showed better diagnostic performance than a single miRNA for PTC detection. The AUCs of the panel were 0.727, 0.771, and 0.862 for the training, testing, and external validation stage, respectively. Meanwhile, the panel showed stable capability in differentiating PTC patients from patients with benign goiters, with an AUC as high as 0.969. For further exploration, the three identified miRNAs were analyzed in tissue samples (23 PTC vs. 23 HCs) and serum-derived exosomes samples (24 PTC vs. 24 HCs), and the altered expression in the tumor also indicated their close relationship with PTC disease.
CONCLUSION
We identify a three-miRNA panel in serum which might serve as a promising biomarker for PTC diagnosis.
Biomarkers, Tumor/genetics*
;
Gene Expression Profiling
;
Humans
;
MicroRNAs/genetics*
;
ROC Curve
;
Thyroid Cancer, Papillary/genetics*
;
Thyroid Neoplasms/genetics*
6.Clinical implication of xenotropic and polytropic retrovirus receptor 1 in papillary thyroid carcinoma.
Journal of Zhejiang University. Medical sciences 2021;50(1):90-96
To investigate the expression of xenotropic and polytropic retrovirus receptor 1 () in papillary thyroid cancer (PTC) and its clinical implication. The HPA and UALCAN databases were used to explore the expression of XPR1 in PTC and normal tissues. The cBioPortal database was used to obtain the clinical data of PTC patients and gene expression profile. The correlation of expression with gender,age,sub-types,T stage,N stage,M stage and clinical stage of patients were analyzed. Cox regression was conducted to analysis the factors affecting the prognosis of PTC patients. The mutation of was assessed through cBioPortal database. GO and KEGG analyses were used to explore the related biological pathway of involved in PTC. HPA database analysis showed that XPR1 was highly expressed in PTC tissue compared with normal tissues. UALCAN analysis displayed that expression was significantly higher in PTC tissue compared with normal tissues (<0.01),and the highest and lowest expressions of were observed in tall cell and follicular sub-type of PTC,respectively. The expression of was correlated with age,sub-types,T stage,N stage and disease stage of PTC patients (<0.05 or <0.01),but was not correlated with gender and M stage (all >0.05). Cox regression analysis showed that was an independent prognostic factor of PTC patients (=2.894,<0.05). The cBioPortal database indicated that the mutation appeared in 6% PTC patients; the mutation type mainly was missense and the mutation point was located at the E615K. Enrichment analysis indicated that might affect the PTC progression through involvement in metabolic pathway. is highly expressed in PTC tissues,which is associated with the prognosis of patients. Metabolic pathway associated with might play an important role in PTC progression,indicating that might be a novel biomarker for diagnosis and treatment of PTC.
Humans
;
Prognosis
;
Receptors, G-Protein-Coupled/genetics*
;
Receptors, Virus/genetics*
;
Thyroid Cancer, Papillary/genetics*
;
Thyroid Neoplasms/genetics*
8.Epigenetic Regulation of RUNX3 in Thyroid Carcinoma.
The Korean Journal of Internal Medicine 2012;27(4):391-393
No abstract available.
Carcinoma/*genetics
;
Core Binding Factor Alpha 3 Subunit/*genetics
;
Humans
;
Thyroid Neoplasms/*genetics
9.Letter to the Editor: Presence of Evolutionary Pressures or Genotyping Error.
Journal of Korean Medical Science 2012;27(3):335-335
No abstract available.
Asian Continental Ancestry Group/*genetics
;
DNA-Binding Proteins/*genetics
;
Female
;
Humans
;
Male
;
Thyroid Neoplasms/*genetics